Global Anti-tumor Drug Market Insights and Forecast to 2031

Report ID: 1229459 | Published Date: Jan 2025 | No. of Page: 117 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Anti-tumor Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Cytotoxic Drugs
        1.2.3 Non-cytotoxic Drugs
    1.3 Market by Application
        1.3.1 Global Anti-tumor Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Alkylating Agents
        1.3.3 Anti-Metabolism Drugs
        1.3.4 Platinum Antineoplastic Agents
        1.3.5 Anthracycline Antitumor Drugs
        1.3.6 Microtubule Stabilizer
        1.3.7 Endocrine Therapy Drugs
        1.3.8 Immunotherapy Drugs
        1.3.9 Gene Therapy Drugs
        1.3.10 Targeted Antineoplastic Drugs
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Anti-tumor Drug Market Perspective (2017-2028)
    2.2 Anti-tumor Drug Growth Trends by Region
        2.2.1 Anti-tumor Drug Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Anti-tumor Drug Historic Market Size by Region (2017-2022)
        2.2.3 Anti-tumor Drug Forecasted Market Size by Region (2023-2028)
    2.3 Anti-tumor Drug Market Dynamics
        2.3.1 Anti-tumor Drug Industry Trends
        2.3.2 Anti-tumor Drug Market Drivers
        2.3.3 Anti-tumor Drug Market Challenges
        2.3.4 Anti-tumor Drug Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Anti-tumor Drug Players by Revenue
        3.1.1 Global Top Anti-tumor Drug Players by Revenue (2017-2022)
        3.1.2 Global Anti-tumor Drug Revenue Market Share by Players (2017-2022)
    3.2 Global Anti-tumor Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Anti-tumor Drug Revenue
    3.4 Global Anti-tumor Drug Market Concentration Ratio
        3.4.1 Global Anti-tumor Drug Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Anti-tumor Drug Revenue in 2021
    3.5 Anti-tumor Drug Key Players Head office and Area Served
    3.6 Key Players Anti-tumor Drug Product Solution and Service
    3.7 Date of Enter into Anti-tumor Drug Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-tumor Drug Breakdown Data by Type
    4.1 Global Anti-tumor Drug Historic Market Size by Type (2017-2022)
    4.2 Global Anti-tumor Drug Forecasted Market Size by Type (2023-2028)
5 Anti-tumor Drug Breakdown Data by Application
    5.1 Global Anti-tumor Drug Historic Market Size by Application (2017-2022)
    5.2 Global Anti-tumor Drug Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Anti-tumor Drug Market Size (2017-2028)
    6.2 North America Anti-tumor Drug Market Size by Type
        6.2.1 North America Anti-tumor Drug Market Size by Type (2017-2022)
        6.2.2 North America Anti-tumor Drug Market Size by Type (2023-2028)
        6.2.3 North America Anti-tumor Drug Market Share by Type (2017-2028)
    6.3 North America Anti-tumor Drug Market Size by Application
        6.3.1 North America Anti-tumor Drug Market Size by Application (2017-2022)
        6.3.2 North America Anti-tumor Drug Market Size by Application (2023-2028)
        6.3.3 North America Anti-tumor Drug Market Share by Application (2017-2028)
    6.4 North America Anti-tumor Drug Market Size by Country
        6.4.1 North America Anti-tumor Drug Market Size by Country (2017-2022)
        6.4.2 North America Anti-tumor Drug Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Anti-tumor Drug Market Size (2017-2028)
    7.2 Europe Anti-tumor Drug Market Size by Type
        7.2.1 Europe Anti-tumor Drug Market Size by Type (2017-2022)
        7.2.2 Europe Anti-tumor Drug Market Size by Type (2023-2028)
        7.2.3 Europe Anti-tumor Drug Market Share by Type (2017-2028)
    7.3 Europe Anti-tumor Drug Market Size by Application
        7.3.1 Europe Anti-tumor Drug Market Size by Application (2017-2022)
        7.3.2 Europe Anti-tumor Drug Market Size by Application (2023-2028)
        7.3.3 Europe Anti-tumor Drug Market Share by Application (2017-2028)
    7.4 Europe Anti-tumor Drug Market Size by Country
        7.4.1 Europe Anti-tumor Drug Market Size by Country (2017-2022)
        7.4.2 Europe Anti-tumor Drug Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Anti-tumor Drug Market Size (2017-2028)
    8.2 Asia-Pacific Anti-tumor Drug Market Size by Type
        8.2.1 Asia-Pacific Anti-tumor Drug Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Anti-tumor Drug Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Anti-tumor Drug Market Share by Type (2017-2028)
    8.3 Asia-Pacific Anti-tumor Drug Market Size by Application
        8.3.1 Asia-Pacific Anti-tumor Drug Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Anti-tumor Drug Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Anti-tumor Drug Market Share by Application (2017-2028)
    8.4 Asia-Pacific Anti-tumor Drug Market Size by Region
        8.4.1 Asia-Pacific Anti-tumor Drug Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Anti-tumor Drug Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Anti-tumor Drug Market Size (2017-2028)
    9.2 Latin America Anti-tumor Drug Market Size by Type
        9.2.1 Latin America Anti-tumor Drug Market Size by Type (2017-2022)
        9.2.2 Latin America Anti-tumor Drug Market Size by Type (2023-2028)
        9.2.3 Latin America Anti-tumor Drug Market Share by Type (2017-2028)
    9.3 Latin America Anti-tumor Drug Market Size by Application
        9.3.1 Latin America Anti-tumor Drug Market Size by Application (2017-2022)
        9.3.2 Latin America Anti-tumor Drug Market Size by Application (2023-2028)
        9.3.3 Latin America Anti-tumor Drug Market Share by Application (2017-2028)
    9.4 Latin America Anti-tumor Drug Market Size by Country
        9.4.1 Latin America Anti-tumor Drug Market Size by Country (2017-2022)
        9.4.2 Latin America Anti-tumor Drug Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Anti-tumor Drug Market Size (2017-2028)
    10.2 Middle East & Africa Anti-tumor Drug Market Size by Type
        10.2.1 Middle East & Africa Anti-tumor Drug Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Anti-tumor Drug Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Anti-tumor Drug Market Share by Type (2017-2028)
    10.3 Middle East & Africa Anti-tumor Drug Market Size by Application
        10.3.1 Middle East & Africa Anti-tumor Drug Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Anti-tumor Drug Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Anti-tumor Drug Market Share by Application (2017-2028)
    10.4 Middle East & Africa Anti-tumor Drug Market Size by Country
        10.4.1 Middle East & Africa Anti-tumor Drug Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Anti-tumor Drug Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Roche
        11.1.1 Roche Company Details
        11.1.2 Roche Business Overview
        11.1.3 Roche Anti-tumor Drug Introduction
        11.1.4 Roche Revenue in Anti-tumor Drug Business (2017-2022)
        11.1.5 Roche Recent Developments
    11.2 Novartis
        11.2.1 Novartis Company Details
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Anti-tumor Drug Introduction
        11.2.4 Novartis Revenue in Anti-tumor Drug Business (2017-2022)
        11.2.5 Novartis Recent Developments
    11.3 Celgene
        11.3.1 Celgene Company Details
        11.3.2 Celgene Business Overview
        11.3.3 Celgene Anti-tumor Drug Introduction
        11.3.4 Celgene Revenue in Anti-tumor Drug Business (2017-2022)
        11.3.5 Celgene Recent Developments
    11.4 Bristol-Myers Squibb
        11.4.1 Bristol-Myers Squibb Company Details
        11.4.2 Bristol-Myers Squibb Business Overview
        11.4.3 Bristol-Myers Squibb Anti-tumor Drug Introduction
        11.4.4 Bristol-Myers Squibb Revenue in Anti-tumor Drug Business (2017-2022)
        11.4.5 Bristol-Myers Squibb Recent Developments
    11.5 Amgen
        11.5.1 Amgen Company Details
        11.5.2 Amgen Business Overview
        11.5.3 Amgen Anti-tumor Drug Introduction
        11.5.4 Amgen Revenue in Anti-tumor Drug Business (2017-2022)
        11.5.5 Amgen Recent Developments
    11.6 Johnson & Johnson
        11.6.1 Johnson & Johnson Company Details
        11.6.2 Johnson & Johnson Business Overview
        11.6.3 Johnson & Johnson Anti-tumor Drug Introduction
        11.6.4 Johnson & Johnson Revenue in Anti-tumor Drug Business (2017-2022)
        11.6.5 Johnson & Johnson Recent Developments
    11.7 Pfizer
        11.7.1 Pfizer Company Details
        11.7.2 Pfizer Business Overview
        11.7.3 Pfizer Anti-tumor Drug Introduction
        11.7.4 Pfizer Revenue in Anti-tumor Drug Business (2017-2022)
        11.7.5 Pfizer Recent Developments
    11.8 Takeda
        11.8.1 Takeda Company Details
        11.8.2 Takeda Business Overview
        11.8.3 Takeda Anti-tumor Drug Introduction
        11.8.4 Takeda Revenue in Anti-tumor Drug Business (2017-2022)
        11.8.5 Takeda Recent Developments
    11.9 Eli Lilly
        11.9.1 Eli Lilly Company Details
        11.9.2 Eli Lilly Business Overview
        11.9.3 Eli Lilly Anti-tumor Drug Introduction
        11.9.4 Eli Lilly Revenue in Anti-tumor Drug Business (2017-2022)
        11.9.5 Eli Lilly Recent Developments
    11.10 AstraZeneca
        11.10.1 AstraZeneca Company Details
        11.10.2 AstraZeneca Business Overview
        11.10.3 AstraZeneca Anti-tumor Drug Introduction
        11.10.4 AstraZeneca Revenue in Anti-tumor Drug Business (2017-2022)
        11.10.5 AstraZeneca Recent Developments
    11.11 Astellas
        11.11.1 Astellas Company Details
        11.11.2 Astellas Business Overview
        11.11.3 Astellas Anti-tumor Drug Introduction
        11.11.4 Astellas Revenue in Anti-tumor Drug Business (2017-2022)
        11.11.5 Astellas Recent Developments
    11.12 Merck & Co
        11.12.1 Merck & Co Company Details
        11.12.2 Merck & Co Business Overview
        11.12.3 Merck & Co Anti-tumor Drug Introduction
        11.12.4 Merck & Co Revenue in Anti-tumor Drug Business (2017-2022)
        11.12.5 Merck & Co Recent Developments
    11.13 Sanofi
        11.13.1 Sanofi Company Details
        11.13.2 Sanofi Business Overview
        11.13.3 Sanofi Anti-tumor Drug Introduction
        11.13.4 Sanofi Revenue in Anti-tumor Drug Business (2017-2022)
        11.13.5 Sanofi Recent Developments
    11.14 Bayer
        11.14.1 Bayer Company Details
        11.14.2 Bayer Business Overview
        11.14.3 Bayer Anti-tumor Drug Introduction
        11.14.4 Bayer Revenue in Anti-tumor Drug Business (2017-2022)
        11.14.5 Bayer Recent Developments
    11.15 Biogen Idec
        11.15.1 Biogen Idec Company Details
        11.15.2 Biogen Idec Business Overview
        11.15.3 Biogen Idec Anti-tumor Drug Introduction
        11.15.4 Biogen Idec Revenue in Anti-tumor Drug Business (2017-2022)
        11.15.5 Biogen Idec Recent Developments
    11.16 Eisai
        11.16.1 Eisai Company Details
        11.16.2 Eisai Business Overview
        11.16.3 Eisai Anti-tumor Drug Introduction
        11.16.4 Eisai Revenue in Anti-tumor Drug Business (2017-2022)
        11.16.5 Eisai Recent Developments
    11.17 Teva
        11.17.1 Teva Company Details
        11.17.2 Teva Business Overview
        11.17.3 Teva Anti-tumor Drug Introduction
        11.17.4 Teva Revenue in Anti-tumor Drug Business (2017-2022)
        11.17.5 Teva Recent Developments
    11.18 Otsuka
        11.18.1 Otsuka Company Details
        11.18.2 Otsuka Business Overview
        11.18.3 Otsuka Anti-tumor Drug Introduction
        11.18.4 Otsuka Revenue in Anti-tumor Drug Business (2017-2022)
        11.18.5 Otsuka Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global Anti-tumor Drug Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Cytotoxic Drugs
    Table 3. Key Players of Non-cytotoxic Drugs
    Table 4. Global Anti-tumor Drug Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Anti-tumor Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Anti-tumor Drug Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Anti-tumor Drug Market Share by Region (2017-2022)
    Table 8. Global Anti-tumor Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Anti-tumor Drug Market Share by Region (2023-2028)
    Table 10. Anti-tumor Drug Market Trends
    Table 11. Anti-tumor Drug Market Drivers
    Table 12. Anti-tumor Drug Market Challenges
    Table 13. Anti-tumor Drug Market Restraints
    Table 14. Global Anti-tumor Drug Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Anti-tumor Drug Revenue Share by Players (2017-2022)
    Table 16. Global Top Anti-tumor Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-tumor Drug as of 2021)
    Table 17. Ranking of Global Top Anti-tumor Drug Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Anti-tumor Drug Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Anti-tumor Drug Product Solution and Service
    Table 21. Date of Enter into Anti-tumor Drug Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Anti-tumor Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Anti-tumor Drug Revenue Market Share by Type (2017-2022)
    Table 25. Global Anti-tumor Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Anti-tumor Drug Revenue Market Share by Type (2023-2028)
    Table 27. Global Anti-tumor Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Anti-tumor Drug Revenue Share by Application (2017-2022)
    Table 29. Global Anti-tumor Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Anti-tumor Drug Revenue Share by Application (2023-2028)
    Table 31. North America Anti-tumor Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Anti-tumor Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Anti-tumor Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Anti-tumor Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Anti-tumor Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Anti-tumor Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Anti-tumor Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Anti-tumor Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Anti-tumor Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Anti-tumor Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Anti-tumor Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Anti-tumor Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Anti-tumor Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Anti-tumor Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Anti-tumor Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Anti-tumor Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Anti-tumor Drug Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Anti-tumor Drug Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Anti-tumor Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Anti-tumor Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Anti-tumor Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Anti-tumor Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Anti-tumor Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Anti-tumor Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Anti-tumor Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Anti-tumor Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Anti-tumor Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Anti-tumor Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Anti-tumor Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Anti-tumor Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Roche Company Details
    Table 62. Roche Business Overview
    Table 63. Roche Anti-tumor Drug Product
    Table 64. Roche Revenue in Anti-tumor Drug Business (2017-2022) & (US$ Million)
    Table 65. Roche Recent Developments
    Table 66. Novartis Company Details
    Table 67. Novartis Business Overview
    Table 68. Novartis Anti-tumor Drug Product
    Table 69. Novartis Revenue in Anti-tumor Drug Business (2017-2022) & (US$ Million)
    Table 70. Novartis Recent Developments
    Table 71. Celgene Company Details
    Table 72. Celgene Business Overview
    Table 73. Celgene Anti-tumor Drug Product
    Table 74. Celgene Revenue in Anti-tumor Drug Business (2017-2022) & (US$ Million)
    Table 75. Celgene Recent Developments
    Table 76. Bristol-Myers Squibb Company Details
    Table 77. Bristol-Myers Squibb Business Overview
    Table 78. Bristol-Myers Squibb Anti-tumor Drug Product
    Table 79. Bristol-Myers Squibb Revenue in Anti-tumor Drug Business (2017-2022) & (US$ Million)
    Table 80. Bristol-Myers Squibb Recent Developments
    Table 81. Amgen Company Details
    Table 82. Amgen Business Overview
    Table 83. Amgen Anti-tumor Drug Product
    Table 84. Amgen Revenue in Anti-tumor Drug Business (2017-2022) & (US$ Million)
    Table 85. Amgen Recent Developments
    Table 86. Johnson & Johnson Company Details
    Table 87. Johnson & Johnson Business Overview
    Table 88. Johnson & Johnson Anti-tumor Drug Product
    Table 89. Johnson & Johnson Revenue in Anti-tumor Drug Business (2017-2022) & (US$ Million)
    Table 90. Johnson & Johnson Recent Developments
    Table 91. Pfizer Company Details
    Table 92. Pfizer Business Overview
    Table 93. Pfizer Anti-tumor Drug Product
    Table 94. Pfizer Revenue in Anti-tumor Drug Business (2017-2022) & (US$ Million)
    Table 95. Pfizer Recent Developments
    Table 96. Takeda Company Details
    Table 97. Takeda Business Overview
    Table 98. Takeda Anti-tumor Drug Product
    Table 99. Takeda Revenue in Anti-tumor Drug Business (2017-2022) & (US$ Million)
    Table 100. Takeda Recent Developments
    Table 101. Eli Lilly Company Details
    Table 102. Eli Lilly Business Overview
    Table 103. Eli Lilly Anti-tumor Drug Product
    Table 104. Eli Lilly Revenue in Anti-tumor Drug Business (2017-2022) & (US$ Million)
    Table 105. Eli Lilly Recent Developments
    Table 106. AstraZeneca Company Details
    Table 107. AstraZeneca Business Overview
    Table 108. AstraZeneca Anti-tumor Drug Product
    Table 109. AstraZeneca Revenue in Anti-tumor Drug Business (2017-2022) & (US$ Million)
    Table 110. AstraZeneca Recent Developments
    Table 111. Astellas Company Details
    Table 112. Astellas Business Overview
    Table 113. Astellas Anti-tumor Drug Product
    Table 114. Astellas Revenue in Anti-tumor Drug Business (2017-2022) & (US$ Million)
    Table 115. Astellas Recent Developments
    Table 116. Merck & Co Company Details
    Table 117. Merck & Co Business Overview
    Table 118. Merck & Co Anti-tumor Drug Product
    Table 119. Merck & Co Revenue in Anti-tumor Drug Business (2017-2022) & (US$ Million)
    Table 120. Merck & Co Recent Developments
    Table 121. Sanofi Company Details
    Table 122. Sanofi Business Overview
    Table 123. Sanofi Anti-tumor Drug Product
    Table 124. Sanofi Revenue in Anti-tumor Drug Business (2017-2022) & (US$ Million)
    Table 125. Sanofi Recent Developments
    Table 126. Bayer Company Details
    Table 127. Bayer Business Overview
    Table 128. Bayer Anti-tumor Drug Product
    Table 129. Bayer Revenue in Anti-tumor Drug Business (2017-2022) & (US$ Million)
    Table 130. Bayer Recent Developments
    Table 131. Biogen Idec Company Details
    Table 132. Biogen Idec Business Overview
    Table 133. Biogen Idec Anti-tumor Drug Product
    Table 134. Biogen Idec Revenue in Anti-tumor Drug Business (2017-2022) & (US$ Million)
    Table 135. Biogen Idec Recent Developments
    Table 136. Eisai Company Details
    Table 137. Eisai Business Overview
    Table 138. Eisai Anti-tumor Drug Product
    Table 139. Eisai Revenue in Anti-tumor Drug Business (2017-2022) & (US$ Million)
    Table 140. Eisai Recent Developments
    Table 141. Teva Company Details
    Table 142. Teva Business Overview
    Table 143. Teva Anti-tumor Drug Product
    Table 144. Teva Revenue in Anti-tumor Drug Business (2017-2022) & (US$ Million)
    Table 145. Teva Recent Developments
    Table 146. Otsuka Company Details
    Table 147. Otsuka Business Overview
    Table 148. Otsuka Anti-tumor Drug Product
    Table 149. Otsuka Revenue in Anti-tumor Drug Business (2017-2022) & (US$ Million)
    Table 150. Otsuka Recent Developments
    Table 151. Research Programs/Design for This Report
    Table 152. Key Data Information from Secondary Sources
    Table 153. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Anti-tumor Drug Market Share by Type: 2021 VS 2028
    Figure 2. Cytotoxic Drugs Features
    Figure 3. Non-cytotoxic Drugs Features
    Figure 4. Global Anti-tumor Drug Market Share by Application: 2021 VS 2028
    Figure 5. Alkylating Agents Case Studies
    Figure 6. Anti-Metabolism Drugs Case Studies
    Figure 7. Platinum Antineoplastic Agents Case Studies
    Figure 8. Anthracycline Antitumor Drugs Case Studies
    Figure 9. Microtubule Stabilizer Case Studies
    Figure 10. Endocrine Therapy Drugs Case Studies
    Figure 11. Immunotherapy Drugs Case Studies
    Figure 12. Gene Therapy Drugs Case Studies
    Figure 13. Targeted Antineoplastic Drugs Case Studies
    Figure 14. Anti-tumor Drug Report Years Considered
    Figure 15. Global Anti-tumor Drug Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 16. Global Anti-tumor Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global Anti-tumor Drug Market Share by Region: 2021 VS 2028
    Figure 18. Global Anti-tumor Drug Market Share by Players in 2021
    Figure 19. Global Top Anti-tumor Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-tumor Drug as of 2021)
    Figure 20. The Top 10 and 5 Players Market Share by Anti-tumor Drug Revenue in 2021
    Figure 21. North America Anti-tumor Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. North America Anti-tumor Drug Market Size Market Share by Type (2017-2028)
    Figure 23. North America Anti-tumor Drug Market Size Market Share by Application (2017-2028)
    Figure 24. North America Anti-tumor Drug Market Size Share by Country (2017-2028)
    Figure 25. United States Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Canada Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Europe Anti-tumor Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 28. Europe Anti-tumor Drug Market Size Market Share by Type (2017-2028)
    Figure 29. Europe Anti-tumor Drug Market Size Market Share by Application (2017-2028)
    Figure 30. Europe Anti-tumor Drug Market Size Share by Country (2017-2028)
    Figure 31. Germany Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. France Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. U.K. Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Italy Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Russia Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Nordic Countries Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Asia-Pacific Anti-tumor Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 38. Asia Pacific Anti-tumor Drug Market Size Market Share by Type (2017-2028)
    Figure 39. Asia Pacific Anti-tumor Drug Market Size Market Share by Application (2017-2028)
    Figure 40. Asia Pacific Anti-tumor Drug Market Size Share by Region (2017-2028)
    Figure 41. China Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Japan Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. South Korea Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Southeast Asia Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. India Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Australia Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Latin America Anti-tumor Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Latin America Anti-tumor Drug Market Size Market Share by Type (2017-2028)
    Figure 49. Latin America Anti-tumor Drug Market Size Market Share by Application (2017-2028)
    Figure 50. Latin America Anti-tumor Drug Market Size Share by Country (2017-2028)
    Figure 51. Mexico Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Brazil Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Middle East & Africa Anti-tumor Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 54. Middle East and Africa Anti-tumor Drug Market Size Market Share by Type (2017-2028)
    Figure 55. Middle East and Africa Anti-tumor Drug Market Size Market Share by Application (2017-2028)
    Figure 56. Middle East and Africa Anti-tumor Drug Market Size Share by Country (2017-2028)
    Figure 57. Turkey Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. Saudi Arabia Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 59. UAE Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 60. Roche Revenue Growth Rate in Anti-tumor Drug Business (2017-2022)
    Figure 61. Novartis Revenue Growth Rate in Anti-tumor Drug Business (2017-2022)
    Figure 62. Celgene Revenue Growth Rate in Anti-tumor Drug Business (2017-2022)
    Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Anti-tumor Drug Business (2017-2022)
    Figure 64. Amgen Revenue Growth Rate in Anti-tumor Drug Business (2017-2022)
    Figure 65. Johnson & Johnson Revenue Growth Rate in Anti-tumor Drug Business (2017-2022)
    Figure 66. Pfizer Revenue Growth Rate in Anti-tumor Drug Business (2017-2022)
    Figure 67. Takeda Revenue Growth Rate in Anti-tumor Drug Business (2017-2022)
    Figure 68. Eli Lilly Revenue Growth Rate in Anti-tumor Drug Business (2017-2022)
    Figure 69. AstraZeneca Revenue Growth Rate in Anti-tumor Drug Business (2017-2022)
    Figure 70. Astellas Revenue Growth Rate in Anti-tumor Drug Business (2017-2022)
    Figure 71. Merck & Co Revenue Growth Rate in Anti-tumor Drug Business (2017-2022)
    Figure 72. Sanofi Revenue Growth Rate in Anti-tumor Drug Business (2017-2022)
    Figure 73. Bayer Revenue Growth Rate in Anti-tumor Drug Business (2017-2022)
    Figure 74. Biogen Idec Revenue Growth Rate in Anti-tumor Drug Business (2017-2022)
    Figure 75. Eisai Revenue Growth Rate in Anti-tumor Drug Business (2017-2022)
    Figure 76. Teva Revenue Growth Rate in Anti-tumor Drug Business (2017-2022)
    Figure 77. Otsuka Revenue Growth Rate in Anti-tumor Drug Business (2017-2022)
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche
Novartis
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co
Sanofi
Bayer
Biogen Idec
Eisai
Teva
Otsuka
Frequently Asked Questions
Anti-tumor Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Anti-tumor Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Anti-tumor Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Thin Film Drugs

Thin Film Drugs market is segmented by players, region (country), by Type and by Application. Pla ... Read More